Indole Derivatives as Anticancer Agents for Breast Cancer Therapy: A Review

Area of Science:

• Oncology
• Medicinal Chemistry
• Pharmacology

Background:

• Breast cancer (BC) is a leading cause of cancer death in women globally.
• Existing BC treatments face challenges due to emerging drug resistance.
• Indole derivatives have demonstrated significant anticancer potential.

Purpose of the Study:

• To comprehensively review synthetic indole derivatives as anticancer agents for breast cancer.
• To analyze the signaling pathways targeted by these indole derivatives.
• To highlight the potential of indoles in overcoming therapeutic resistance in breast cancer.

Main Methods:

• Literature review of synthetic indole derivatives with anticancer activity against breast cancer.
• Analysis of studies detailing the mechanisms of action and targeted signaling pathways.
• Synthesis and evaluation of novel indole-based compounds.

Main Results:

• Multiple synthetic indole derivatives exhibit potent anti-breast cancer activity.
• These derivatives act through various signaling pathways, including those involved in cell proliferation and apoptosis.
• Indole compounds show promise in overcoming resistance mechanisms observed with current therapies.

Conclusions:

• Indole derivatives represent a promising class of compounds for novel breast cancer therapies.
• Targeting specific signaling pathways with indole-based agents may enhance treatment efficacy.
• Further research into indole derivatives is warranted to develop new drugs free from resistance issues.